Mechanisms of the Development of ALLergy (MeDALL)

The MeDALL Project is funded by the 7th Framework Programme (FP7) as a consortium of 23 partners, of both public and private institutions, which seeks to gather leading experts in clinical allergy (Allergology, asthma, atopic dermatitis, food allergy and pediatrics), epidemiology, genetics, immunology molecular biology, allergen biochemistry and bioinformatics. Together the stakeholders collaborate to investigate the causes of allergy in order to improve the health of European citizens with results which can improve the quality of life among allergy patients across Europe. The project specifically targets the improvement of early diagnosis, primary and secondary prevention strategies and the development of cost-effective treatments for allergic disorders.

Additional information is available for download below or by visiting the MeDALL website.

EFA Presentation at MeDALL Kick-off Event         MeDALL Brochure



  • EFA in Meetings

    Oct 31, 2013

    [...] to share our experience and best practices through participation in EU research projects such as MeDALL and U-BIOPRED, and when patients are on the driving seat creating their own evidence: new project [...]

  • [...] projects we will redefine the diseases to find better treatments”, explained Charles Auffray from MeDALL, an EU project that uses data from more than 40,000 allergic children to improve early diagnosis [...]

Leave a Reply

EFA eZine Archive